Ahram Biosystems launches cost-effective, high-performance portable PCR system

NewsGuard 100/100 Score

Ahram Biosystems, Inc., a leading innovator of new life science tools, today announced the launch of Palm PCR F1-12, the economy model of its innovative portable PCR system. The F1-12 system is a cost-effective, high-performance portable PCR system, delivering PCR amplification with high speed and sensitivity in a fully portable format.

The Palm PCR F1-12 system provides three "Standard Fast" speed levels delivering 30-cycle PCR amplification within 30 minutes down to 24 minutes. The amplification sensitivity reaches to near single-copy level below 10 copies. The dynamic range of the PCR amplification is up to 1 kbp. Like other Palm PCR series, it is battery-powered (more than 4 hours of continuous operation on a single charge) and represents high temperature uniformity (less than +/- 0.1 degrees C) and a small footprint and light weight (71 mm x 121 mm x 47 mm or 2.8" x 4.76" x 1.85", 350 g).

The high speed and high sensitivity of the F1-12 system and its affordable price make it ideal for a wide range of downstream applications that require fast and sensitive nucleic acid amplification. Examples include POCT (point-of-care testing), food quality assurance, forensics, educational uses and many other applications of genetic identification purposes. The battery-powered, full portability makes the F1-12 system particularly invaluable where in-field or on-site PCR amplification is crucial. The Palm PCR F1-12 system enables users to perform highly sensitive and accurate PCR amplification in a fully portable format while saving both money and time.

Source:

Ahram Biosystems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MGI Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine